µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º ='4)E6ea?
|mRlP5
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ q165S
(S+/e5c)
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) JN` $Fq+
p=E#!cn3
1. ICAM-1 v7KBYN
9\WtcLx
2. interleukin 12(IL-12) U.I
w/T-5
jn(!6\n"
3. tumor infiltrating lymphocyte
YaC[S^p
o 7tUv"Rs
4. TCR/CD3 complex .s,04xW\
srAWet
5. hematopoietin receptor family K?!W9lUq
dhnX\/
6. individual idiotype(IdI) vazA@|^
8
<Lxp t
7. integrin Eri007? D
bfZt <-
8. colony-stimulatory factor (CSF) +75"Q:I
2YY4 XHQS
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© ;]m;p,$
D]}~` SO
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? IO
0n
T
UF-'(
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ }[UH1+`L
~1}fL 1~5
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠeWex/ m
XxdD)I
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ Et
(H6O8
Shy.:XI
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) (GL'm[V
U>.5vK.+
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ JU5,\3Lz#
tx9%.)M:n
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) L xIKH
G
id :
^|
3. immunoglobulin superfamily (IgSF) C(B"@
j#P4&
4. selectin ',WJ'g
2YWO'PL
5. anti-idiotypic antibody (¦ÁId) uuD2O )v
`fX\pOk~e
6. major histocompatibility complex(MHC) L/WRVc6
Et-|[ eL
7. immunotolerance z2,NWmP|w
i>CR{q
8. biological reponse modifier(BRM) !.O[@A\.-
is^R8a
9. immune reponse gene (Ir gene) e@Ev']
6]<yR>
'
10. reshaped antibody (or reconstituted antibody) =+T0[|gc(r
04v
~K
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© *& );-r`.
^z,B}Nz
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ 9 4lt?|3=
#>lbpw
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? lnjs{`^
KV&6v`K/N
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ RN@)nc_
BOM0QskLf
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? w;AbJCv2
4Jc~I
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ [`tNa Vg
[U^Cz{G
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? tK *y/S
5-({z%:P
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ 2Y[n
-p7
HQ/
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ k6z]"[yu
Oz]$zRu/0
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? X#h a*u~U
w
EI?
9
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ E1Q#@*rX>
DXO'MZon3
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: LXrk5>9
a;~< iB;3"
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ScVbo3{m*T
a[}?!G-Wt|
̉񧄤 g@/}SJh/>
M80O;0N%A
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© :h3
U^
vAeVQ~
1. CD8 ==%5Ci7qMy
j*f\Z!EeZ
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) toOdL0hCe
3tkCmB
3. immunoglobulin fold(Ig fold) |_+l D|'
fWs*u[S
4. cadherin (Ca-dependent cell adhesion moleculers) sP%b?6
gCVOm-*:
5. idiotype-anti-idiotypic antibody immune network theory F1M:"-bda
jt* B0'S
a
6. HLA class II antigen lU$0e09
TpYh)=;k
7. complementarity-determining region (CDR) UL%a^' hR
H<?s
[MH[
8. perforin(or pore-forming protein ,PFP) TK~KM
{L.uLr_?e
9. high affinity IL-2 receptor 1O,8=,K2a
7+X~i@#rU
10. artificial active immunization Vu E$-)&)
a <F2]H=J
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© in K
;n
AA=
eWg
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦ÓᣠPQh s^D
%@TC-
xx
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 w
$`w
-g|ji.
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ ^kz(/c/ ?
M1*bT@6
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ 5)h fI7{d
)1HWD]>4
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ ?`O^;f
E7aG&K
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? * >8EMq\^
j4]3}t0q
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ hv\Dz*XTs0
,j.bdlI#
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ #V#!@@c;?
y%kZ##
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ b>
k2@
P*VZ$bUe5@
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ -%^'x&e
1)z
Xv
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© j F/S2Ty2
n5^57[(
1. immunoglobulin gene rearrangement b`^Q ':^A
9
Qa_3+.B
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) 257$ !
w&Gc#-B
3. flow cytometry(FCM) fBv:
TC%
*kYGXT,f]
4. carrier effect c$tX3ug6I
5/7(>ivn
5. positive selection of T lymphocytes in thymus >TBXT+
$AE5n>ZD$
6. mouse TH1(Th1) and TH2(Th2) subsets #(i
pF
nbf/WOCk
7. perforin (pore-forming protein ,PFP) N@}h
|g!d[ct]
8. ADCC(antibody-dependent cell-mediated cytotoxicity) iR88L&U>
tpO'<b
9. SH-2(src-homology region 2) y)CvlI
6ST(=X_C
10. Ab2¦Â (internal image) !jSgpIp
}f?[m&<
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© QHf&Z*Xtl
*pv<ZF0>
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? l!&ik9m
Ef28
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? '@Rk#=85Z
6l;2kztGp
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ[3nWxFz$R
kROIVO1|`
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ <r t$~}
o.0tD
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠF4==a8
9 i/
(
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) 4R\jZ@D
ftR& 5!Wm
ÃâÒßѧרҵ£º tO:JB&vO2
OoH-E.lp
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ x;z=[eE
WGUw`sc\
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? F=1 #qo<?
T>rmm7F
´«È¾²¡Ñ§×¨Òµ£º :,Y1#_\
_OuNX.yrG
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ &s vg<UZ
`Y4K w
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ Q'Osw"
N\g=9o|Q
Ïû»¯×¨Òµ£º 0r1GGEW`s
il@>b
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ ,mp<<%{u
"}*D,[C5e
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? 2WFZ6
7N[".V]c
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ 4i)5=H
KxX [8
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 8e*skL
W?.469yy
1. Fas(CD95)/FasL eb\S pdM6
T3{~f
2. common chain of cytokine receptor |du%c`wl
lTMY|{9
3 . TCR/CD3 complex 3P2{M}WIl
7b>_vtrt
4. negaive selection of thymocytes znsQ/[
,X^3.ILz
5. artificial active immune )4=86>XJT
B\RAX#
6. anti-idiotypic 3&^hf^yg
Jq&Hz$L|
7. IgSF
|gO7`F2
lfHN_fE>Mq
8. Integrin rwLKY.J]
l2St)`K8
9. chemokine @^UgdD,BS,
$C7a#?YF,
10. B7/CD28 Ra|P5
):G%o
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© {k3ItGQ_
.8|wc
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ paIjXaU1Mb
,yGbMOV
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ 'r]6 GC8Z$
Q&]|W
Xv
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ !YA X.e
QGuqV8 y0
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ $vu*#
.w
9?,i+\)qK@
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ 2]mV9B
~x,_A>a
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ jlj ge=#c2
N4+Cg t(
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© <4G
y~?
[ *Dj:A)V^
1. B7/CD28 Wm6qy6HR
?-)!dl%N
2. Th1 subset X+]>pA
Q)0KYKD+@
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© J~5V7B
G*N[t w
4. antibody affinity maturation t\ oud{Cv
**h4M2'C
5. AP-1 nv_v FK
-NJpql{Cb
6. single chain variable fragment£¨ScFv£© N~=I))i
Dq<la+VlO
7. NK cell receptor cRf F!EV
Vq+7 /+2"
8. Zinkernagel-Doherty phenomenon [cnuK
rByth,|
9. Ig fold 3FR(gr$X
06]3+s{{
10. CD40/CD40L X\Bl?
F
3cghg._
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© @6G)(NGD
/.0K#J:
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ zTcz+3x
&AJ bx
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ ,}IcQu'O
/#Pm'i>B
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ zj r($?
="$w8iRU
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ ~k&b
O6
Py
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ @
3=pFYW)
{'4#{zmp
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ 73X*|g[O
W5Z
-s.o
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ gg#9I(pX
P{)D_Bi
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© $Xwk8<
@FIL4sb
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© tM"vIz 05
}BM`4/
1.Co-stimulators (or co-stimulating molecules) \YzKEYx+
bQ>wyA+G&E
2.NK-kB AVjRhe
M@es8\&S.
3.Immunoglobulin superfamily y<6Sl6l*
/4Wf\
Zu
4.antigen-presenting cell (APC) P- ZvW<M
"}_J"%
5.death domain P\Qvj7_
9c]$d
6.CCR and CXCR 0E#??gN
/b
#w.>e
7.Lectin (or mitogen) g"n>v
c7
lB _9b_|2
8.Clusters of differentiation, CD) 8US35t:M
pHR`%2!"t
9.B7 family UZt3U
a&J
6?}|@y^fb
10.Cytotoxic T lymphocyte, CTL) ^e^-1s
S
\
&|xMw[
11.IL-15 and IL-15 receptor (IL-15R) !jl^__
.DR
e;=R8i
12.MHC restriction pWzYC@_W
DA=LR
13.Affinity-chromatography 8Q/cJ+&
%62|dhl6
14.Cyctosprin A, CsA d
KPXs-5
U!+O+(
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) Z]LP18m9kl
uq6>K/~D
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© sifj
mNP
(~\HizSl
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 9r\p4_V
85"Szc-#
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ |LIcq0Z
@QJPcF"
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ pPs TgGai
_Hq)@AI
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 0Q>
8}oe))b
ÃâÒßѧרҵ£º Yc[vH=gV}
(Ms #)E
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ #m7evb5eg*
l}S96B
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ J'#o6Ud
\SmYxdU'>
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ vEt=en
Q
KdlUa^}D
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ)
0^P9)<k'
,
Z1 &MuV
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) 4.%/u@rAi
=;8q
`
1. ADCC(antibody dependent cell-mediated cytotoxicity) l0!`>Xx[b
4}Os>M{k
2. »·æß¾úËØ(cyclosporin) `sdbo](76
7m(9|Y:Q.
3. KIR(killer cell inhibitory receptor) k~Y_%#_
jfR!M07|
4. HLDA(human leucocyte differentiation antigen) sBN4:8
<UwA5X`0e.
5. Interleukin 18(IL-18) {y!77>Q/
:n}t7+(>U
6. ÕûºÏËØ(integrin) AdF[>Wv
oM}P Wf-
7. Fas/FasL FbPoyh
=-uk7uZM
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) Z+;670Z
xe1
xP@e?
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) mhnK{M @56
'6>nXp?)r
10. Th1/Th2 J}&xS<
<Y#EiC.
11. »ùÒòÒßÃç(DNAÒßÃç) itIzs99j
TL_8c][.4$
12. chemokines and chemokine receptor mH} 1Zy
E%C02sI
13. ÃâÒßÄÍÊÜ /7<l`RSr
H23-%+*J
14. ¹²´Ì¼¤·Ö×Ó $q;dsW,8
Z:}d\~`x$%
15. ËÀÍö½á¹¹Óò(death domain) 2s@<k1EdPl
kC)ye"r
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) K%A:W
R nf$
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? M
7;P)da
'
Nv*ePz
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠ\a8<DR\@O
aJ1
<X8
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î 7Z/KXc[b
(r?41?5K
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ R1X{=ct
fWywegh
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
.* xaI+:
0XBv8fg
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ +Q3i&"QB.
;V~[kF=t0
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) ^F `
!giL~}j(R
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ xFt[:G`\}u
#?Z>o16,u
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ +KV`+zic+
;{79d8/=
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£